fda compounding peptides bpc 157 warning letter FDA's Overreach on Compounded FDA advisory committee votes to

TB-500 itself remains an investigational compound, meaning it has not been approved as a standalone drug by the FDA

When using the preparation with other medicines Please inform your doctor or pharmacist if you are taking/using or have recently taken/used other medicines, even if they are non-prescription medicines

Alcohol is metabolized in the liver through a process called oxidation

If you have additional questions, Pierre Rojas, DO is here to answer your questions and get you started

Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials

Expert Guidance Our highly trained team, led by APRN Mayte Liz Fuster, ensures you receive the right treatments tailored to your goals